Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14557 | 695 | 30.7 | 41% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
644 | 12881 | THYMUS//THYMIC NURSE CELLS//INTERLEUKIN 2 RECEPTOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | T LYMPHOCYTE IMMUNOLOGY | Author keyword | 2 | 67% | 0% | 2 |
2 | CLIN HOSP O NOVOSEL MED MED | Address | 1 | 100% | 0% | 2 |
3 | MITOGEN INDUCED CELLULAR CYTOTOXICITY | Author keyword | 1 | 100% | 0% | 2 |
4 | INTERPHASE DEATH | Author keyword | 1 | 33% | 0% | 2 |
5 | LYMPHOCYTE B DIFFERENTIATION | Author keyword | 1 | 50% | 0% | 1 |
6 | MOUSE ROSETTES | Author keyword | 1 | 50% | 0% | 1 |
7 | SURFACE IMMUNOGLOBULIN INTENSITY | Author keyword | 1 | 50% | 0% | 1 |
8 | SURFACE MEMBRANE MARKERS | Author keyword | 1 | 50% | 0% | 1 |
9 | VENETIAN MOL MED VIMM | Address | 1 | 50% | 0% | 1 |
10 | ACYCLOGUANOSINE | Author keyword | 0 | 33% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IGM LAMBDA | 1 | 50% | 0% | 2 |
2 | MEMBRANE PHENOTYPE | 1 | 50% | 0% | 1 |
3 | PLASMACYTOID DIFFERENTIATION | 1 | 50% | 0% | 1 |
4 | HEMOGLOBIN ACCUMULATION | 0 | 33% | 0% | 1 |
5 | INDUCED PLASMACYTOID DIFFERENTIATION | 0 | 33% | 0% | 1 |
6 | B PROLYMPHOCYTIC LEUKEMIA | 0 | 25% | 0% | 1 |
7 | CD30 MOLECULE | 0 | 14% | 0% | 1 |
8 | INDUCED LYMPHOPROLIFERATIVE RESPONSE | 0 | 14% | 0% | 1 |
9 | CD1 EXPRESSION | 0 | 11% | 0% | 1 |
10 | CD95 EXPRESSION | 0 | 10% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CHRONIC LYMPHOCYTIC-LEUKEMIA - RECENT ADVANCES IN BIOLOGY AND TREATMENT | 1985 | 163 | 164 | 28% |
IMMUNOREGULATORY CELL DYSFUNCTION IN CHRONIC B-CELL LEUKEMIAS | 1990 | 30 | 84 | 27% |
IMMUNE DEFICIENCIES IN CHRONIC LYMPHOCYTIC-LEUKEMIA AND MULTIPLE-MYELOMA | 1992 | 7 | 63 | 27% |
A REVIEW OF THE PROGNOSTIC ROLE OF CYTOGENETIC, PHENOTYPIC, MORPHOLOGICAL, AND IMMUNE FUNCTION CHARACTERISTICS IN CHRONIC LYMPHOCYTIC-LEUKEMIA | 1987 | 12 | 18 | 33% |
REACTIVITY OF B-LEUKEMIC LYMPHOCYTES OF PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA TO PWM AND PHA | 1987 | 3 | 5 | 60% |
ROLE OF IMMUNOTYPING IN CHRONIC LYMPHOCYTOSIS - REVIEW OF THE NATURAL-HISTORY OF THE CONDITION IN 145 ADULT PATIENTS | 1988 | 7 | 19 | 26% |
LYMPHOCYTES-T IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA | 1985 | 3 | 30 | 80% |
Differentiation therapy of leukemia: achievements, limitations and future prospects | 1998 | 29 | 154 | 8% |
RECEPTORS FOR MOUSE ERYTHROCYTES ON HUMAN-LYMPHOCYTES - TECHNICAL ASPECTS | 1984 | 3 | 17 | 71% |
ULTRASTRUCTURAL-LOCALIZATION OF SURFACE AND INTRACELLULAR IMMUNOGLOBULIN IN HUMAN LYMPHOID-CELL SUSPENSIONS | 1984 | 1 | 6 | 83% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN HOSP O NOVOSEL MED MED | 1 | 100% | 0.3% | 2 |
2 | VENETIAN MOL MED VIMM | 1 | 50% | 0.1% | 1 |
3 | HAEMATOL CLIN IMMUNOL BRANCH | 0 | 33% | 0.1% | 1 |
4 | INTERNAL MED CLIN IMMUNOBIOL | 0 | 17% | 0.1% | 1 |
5 | IST EMATOL LA SERAGNOLI | 0 | 17% | 0.1% | 1 |
6 | CATTEDRA EMATOL ANAT PATOL | 0 | 100% | 0.1% | 1 |
7 | CLIN INTERNAL HEMATOL DIS | 0 | 100% | 0.1% | 1 |
8 | DR NOVOSEL MED MED | 0 | 100% | 0.1% | 1 |
9 | KAROLINSKA MED ONCOL HEMATOL SECT | 0 | 100% | 0.1% | 1 |
10 | MOL MODELLING SECT MMS | 0 | 100% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000249590 | T CELL ASSOCIATED ANTIGENS//CD8 ANTIGEN//B CELL NON HODGKIN LYMPHOMA B NHL |
2 | 0.0000214040 | HISTIOCYTES MACROPHAGES//LYMPHOCYTE COLONY ASSAY//INSITU LABELING |
3 | 0.0000123349 | T CELL PROLYMPHOCYTIC LEUKEMIA//T PLL//TCL1 |
4 | 0.0000117865 | HAIRY CELL LEUKEMIA//HAIRY CELL LEUKAEMIA//HAIRY CELL LEUKEMIA VARIANT |
5 | 0.0000117600 | CHRONIC LYMPHOCYTIC LEUKEMIA//CLL//B CLL |
6 | 0.0000115078 | JOURNAL OF MOLECULAR AND CELLULAR IMMUNOLOGY//J11D//MED ICRF HUMAN TUMOUR IMMUNOL GRP |
7 | 0.0000102612 | ALPHA NAPHTHYL ACETATE ESTERASE//ANAE//RESORCINOL BIS DIPHENYLPHOSPHATE |
8 | 0.0000096470 | IMMUNOCYTOFLUOROMETRY//CLASS II DR//CLIN STOMATOL 1 |
9 | 0.0000082081 | IGD MYELOMA//IGD RECEPTOR//IMMUNOGLOBULIN D |
10 | 0.0000081747 | LEUKEMIA CELL DIFFERENTIATION//DUNN OSTEOSARCOMA CELLS//LOW DOSE CYTOSINE ARABINOSIDE |